跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Recombicyte - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Recombicyte
Approved
STANDARD
Recombicyte
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
de93dee9ac0b6b09
Company
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
de93dee9ac0b6b09
Drug Approval Philippines Name
Recombicyte
Product Name
Recombicyte
Registration Number
BR-698
Brand Name
Recombicyte
Generic Name
Filgrastim
Dosage Form
Solution for Injection (IV/SC)
Dosage Strength
300mcg/0.9mL
Manufacturer
Beijing Four Rings Bio-Pharmaceutical Co., Ltd.
Importer
Global Pharmatrade
Distributor
Global Pharmatrade
Issuance Date
27 April 2021
Expiry Date
01 July 2026
Pharmacologic Category
HEMATOPOIETIC GROWTH FACTOR
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
de93dee9ac0b6b09
Type
Standard
Back to Philippines FDA Approvals